Summary

Company Announcement Date: May 11, 2026 FDA Publish Date: May 18, 2026 Product Type: Dietary Supplements Reason for Announcement:

Recall Reason Description

Undeclared Sildenafil, Tadalafil, and Flibanserin

Company Name: Best Supplements Best Prices Brand Name:

Brand Name(s)

Best Supplements Best Prices

Product Description:

Product Description

Dietary supplement for sexual enhancement

Company Announcement

FOR IMMEDIATE RELEASE LOS ANGELES, CA – May 11, 2026 – Best Supplements Best Prices is voluntarily recalling all lots of WAP Sensual Enhancement capsules to the consumer level. FDA analysis has found the product to contain undeclared sildenafil, tadalafil, and flibanserin.

Sildenafil and tadalafil are ingredients in FDA-approved prescription drugs used to treat erectile dysfunction. These undeclared ingredients may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Flibanserin is the active ingredient in an FDA-approved prescription drug used to treat low sexual desire in women. Flibanserin can cause drowsiness, sedation, and dangerously low blood pressure and fainting, especially when combined with alcohol.

WAP Sensual Enhancement UPC: 80174 00462 was marketed as a dietary supplement for sexual enhancement and was distributed nationwide in the USA via the internet on www.ebay.com.

Best Supplements Best Prices is notifying its customers by email and is arranging for a full refund of all recalled products. Consumers that have WAP Sensual Enhancement which is being recalled should stop using the product and dispose of it.

Consumers with questions regarding this recall can contact Best Supplements Best Prices at [email protected] or by calling 818-856-2141 Monday – Saturday 9am-5pm. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.